AU2003220466A1 - Delayed release dosage forms - Google Patents

Delayed release dosage forms

Info

Publication number: AU2003220466A1
Authority: AU; Australia
Prior art keywords: dosage forms; delayed release; release dosage; delayed; forms
Prior art date: 2002-09-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003220466A

Inventor

Narendra Parikh

David Wynn

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kenvue Brands LLC

Original Assignee

McNeil PPC Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-28

Filing date

2003-03-21

Publication date

2004-04-19

2002-09-28 Priority claimed from PCT/US2002/031062 external-priority patent/WO2003026626A2/en

2003-03-21 Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc

2003-03-21 Priority claimed from PCT/US2003/008845 external-priority patent/WO2004028510A1/en

2004-04-19 Publication of AU2003220466A1 publication Critical patent/AU2003220466A1/en

Status Abandoned legal-status Critical Current

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
PCT/US2002/031062 WO2003026626A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
AU2002347776		2002-09-28
PCT/US2002/031024 WO2003026625A1 (en)	2001-09-28	2002-09-28	Modified release dosage forms
AU2002334741		2002-09-28
AU2002334743		2002-09-28
AUPCT/US2002/031024		2002-09-28
AUPCT/US2002/031129		2002-09-28
PCT/US2002/031129 WO2003026630A1 (en)	2001-09-28	2002-09-28	Dosage forms having an inner core and outer shell with different shapes
PCT/US2002/031163 WO2003026627A1 (en)	2001-09-28	2002-09-28	Composite dosage forms
PCT/US2002/031117 WO2003026629A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
PCT/US2003/008845 WO2004028510A1 (en)	2002-09-28	2003-03-21	Delayed release dosage forms

Publications (1)

Publication Number	Publication Date
AU2003220466A1 true AU2003220466A1 (en)	2004-04-19

Family

ID=34271652

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
AU2003220466A Abandoned AU2003220466A1 (en)	2002-09-28	2003-03-21	Delayed release dosage forms
AU2003218359A Abandoned AU2003218359A1 (en)	2002-09-28	2003-03-21	Polymer composition and dosage forms comprising the same
AU2003225944A Abandoned AU2003225944A1 (en)	2002-09-28	2003-03-21	Modified release dosage forms with two cores and an opening
AU2003220472A Abandoned AU2003220472A1 (en)	2002-09-28	2003-03-21	Modified release dosage form with two cores

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
AU2003218359A Abandoned AU2003218359A1 (en)	2002-09-28	2003-03-21	Polymer composition and dosage forms comprising the same
AU2003225944A Abandoned AU2003225944A1 (en)	2002-09-28	2003-03-21	Modified release dosage forms with two cores and an opening
AU2003220472A Abandoned AU2003220472A1 (en)	2002-09-28	2003-03-21	Modified release dosage form with two cores

Country Status (8)

Country	Link
JP (3)	JP2006517182A (en)
CN (3)	CN1700907A (en)
AT (1)	ATE444739T1 (en)
AU (4)	AU2003220466A1 (en)
BR (5)	BR0314787A (en)
CA (3)	CA2500311A1 (en)
DE (2)	DE60329614D1 (en)
MX (1)	MXPA05003283A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2470463C (en)	2004-06-09	2012-09-18	Lornamead Brands, Inc.	Tooth whitening products and methods of making the same
SA07280459B1 (en) *	2006-08-25	2011-07-20	بيورديو فارما إل. بي.	Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic
WO2009153635A1 (en) *	2008-06-19	2009-12-23	University Of Witwatersrand, Johannesburg	A chronotherapeutic pharmaceutical dosage form
US20130011449A1 (en) *	2010-03-23	2013-01-10	Shiori Tomioka	Solid preparation
WO2013009701A2 (en) *	2011-07-08	2013-01-17	The University Of North Carolina At Chapel Hill	Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
HK1203162A1 (en) *	2012-02-07	2015-10-23	麦克内尔-Ppc股份有限公司	Rapidly disintegrating coated tablets
WO2013183497A1 (en) *	2012-06-05	2013-12-12	武田薬品工業株式会社	Dry-coated tablet
AU2015317469B2 (en) *	2014-09-19	2018-03-15	The Procter & Gamble Company	Pulsed release phenylephrine dosage forms
KR102810926B1 (en)	2017-12-20	2025-05-22	퍼듀 퍼머 엘피	Abuse-deterrent morphine sulfate formulation
MX2020006886A (en) *	2017-12-29	2020-11-11	Laxxon Medical Ag	Drug delivery system.
US12409163B2 (en)	2021-07-30	2025-09-09	Evecxia Therapeutics, Inc.	Method of enhancing 5-hydroxytryptophan (5-HTP) exposure
MX2024001390A (en) *	2021-07-30	2024-05-17	Evecxia Therapeutics Inc	5-hydroxytryptophan gastroretentive dosage forms.
CN115295864B (en) *	2021-11-09	2023-08-11	深圳市德方创域新能源科技有限公司	Positive electrode lithium supplementing additive and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0662824A1 (en) *	1992-09-30	1995-07-19	Pfizer Inc.	Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
DE4431653C2 (en) *	1994-09-06	2000-01-20	Lohmann Therapie Syst Lts	Coated tablet for the controlled release of active substances, a process for their preparation and their use
IT1282576B1 (en) *	1996-02-06	1998-03-31	Jagotec Ag	PHARMACEUTICAL TABLET SUITABLE TO GIVE THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES
US6602521B1 (en) *	1998-09-29	2003-08-05	Impax Pharmaceuticals, Inc.	Multiplex drug delivery system suitable for oral administration
EP1275373A4 (en) *	2000-04-17	2007-04-04	Astellas Pharma Inc	Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
PT1368006E (en) *	2001-02-13	2006-08-31	Astrazeneca Ab	NEW MODIFIED LIBERTACAO FORMULA

2003
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 DE DE60329614T patent/DE60329614D1/en not_active Expired - Lifetime
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/en not_active IP Right Cessation
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/en active Pending
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/en active Pending
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/en active Pending
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/en active Pending
- 2003-03-21 AT AT03714356T patent/ATE444739T1/en not_active IP Right Cessation
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/en not_active Application Discontinuation
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/en not_active Application Discontinuation
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/en active Pending
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/en active Pending
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/en unknown
- 2003-03-21 DE DE60335270T patent/DE60335270D1/en not_active Expired - Lifetime
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/en not_active Application Discontinuation
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2003218359A1 (en)	2004-04-19
CA2500312A1 (en)	2004-04-08
DE60329614D1 (en)	2009-11-19
MXPA05003283A (en)	2005-11-23
CA2500313C (en)	2011-06-07
CN1700907A (en)	2005-11-23
BR0314547A (en)	2005-08-09
BR0314787A (en)	2005-07-26
JP2006517183A (en)	2006-07-20
AU2003225944A1 (en)	2004-04-19
JP2006517182A (en)	2006-07-20
CA2500311A1 (en)	2004-04-08
JP2006517514A (en)	2006-07-27
BR0314781A (en)	2005-07-26
DE60335270D1 (en)	2011-01-20
ATE444739T1 (en)	2009-10-15
BR0314777A (en)	2005-07-26
CN1700908A (en)	2005-11-23
AU2003220472A1 (en)	2004-04-19
CN1684671A (en)	2005-10-19
BR0314804A (en)	2005-08-02
CA2500313A1 (en)	2004-04-08

Publication	Publication Date	Title
IL174343A0 (en)	2009-02-11	Delayed released dosage forms
AU2003262059A1 (en)	2004-04-30	Sustained release preparation
AU2003243665A1 (en)	2004-01-06	Dispenser for solid objects
AU2003221497A1 (en)	2003-09-22	Pharmaceutical microparticles
AU2003225031A1 (en)	2003-11-11	Eptfe-reinforced perfluoroelastomers
AU2003265866A1 (en)	2004-03-29	Targeted release
AU2003224111A1 (en)	2003-11-17	Substituted pyrazolo-pyrimidine-4-ones
AU2003279910A1 (en)	2004-05-04	Solid objects dispensers
WO2003072535A8 (en)	2004-09-30	Substituted hydroxyethylamines
AU2003238043A1 (en)	2004-01-23	Substituted imidazotriazines
AU2003245984A1 (en)	2004-01-23	Hetero-cyclicaly substituted imidazotriazines
AU2003219814A1 (en)	2003-09-09	Release agents
AU2003212776A1 (en)	2003-10-08	Microparticles
AU2003220466A1 (en)	2004-04-19	Delayed release dosage forms
IL163887A0 (en)	2005-12-18	Controlled release dosage forms
AU2003294900A1 (en)	2004-07-22	Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003206718A1 (en)	2003-11-17	Dosage dispenser
AU2003212366A1 (en)	2003-10-08	Substituted 4-aminocyclohexanols
AU2003261067A1 (en)	2004-04-30	Modified release ketoprofen dosage form
AU2003255890A1 (en)	2004-03-11	Nitrofurantoin controlled release dosage form
AUPS167602A0 (en)	2002-05-16	An improved modified release preparation
AU2003220479A1 (en)	2004-04-19	Modified release dosage forms
HK1067063A (en)	2005-04-01	Controlled release dosage forms
AU2003205935A1 (en)	2003-09-02	Forming means
AU2002334741A1 (en)	2003-04-07	Modified release dosage forms

Legal Events

Date	Code	Title	Description
2005-06-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase